SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Referencias del artículo

PAEZ, Olga B et al. Hipertensión de guardapolvo blanco: evolución a hipertensión sostenida luego de 10 años de seguimiento. Rev. argent. cardiol. [online]. 2012, vol.80, n.3, pp. 217-221. ISSN 1850-3748.

    1. Pickering TG, James GD, Boddie C, Harshfield G, Blank S, Laragh J. How common is white coat hypertension? JAMA 1988;259:225-8. [ Links ]

    2. Drayer JI, Weber MA, Nakamura DK. Automated ambulatory blood pressure monitoring: A study in age-matched normotensive and hypertensive men. Am Heart J 1985;109:1334-8. [ Links ]

    3. 2007 Guidelines for the Management of Arterial Hypertension; The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105-87. [ Links ]

    4. Perloff D, Grim C, Flack J, Frohlich E, Hill M, McDonald M, et al. The prognostic value of ambulatory blood pressures. JAMA 1983;249:2792-8. [ Links ]

    5. Pierdomenico SD, Cuccurullo F. Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta-analysis. Am J Hypertens 2010;24:52-8. [ Links ]

    6. Kario K, Shimada K, Schwartz JE, Matsuo T, Hoshide S, Pickering TG. Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension. J Am Coll Cardiol 2001;38:238-45. [ Links ]

    7. Ohkubo T, Kikuya M, Metoki H, Asayama K, Obara T, Hashimoto J, et al. Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol 2005;46:508-15. [ Links ]

    8. Majul C, Páez O, De María M, Cragnolino R, López A, Gorosito A y col. Hipertensión por guardapolvo blanco: ¿es una entidad intermedia entre normotensos e hipertensos sostenidos? Rev Argent Cardiol 2001;69:260-6. [ Links ]

    9. Consenso de Hipertensión Arterial. Consejo Argentino de Hipertensión Arterial "Dr. Eduardo Braun Menéndez". Rev Argent Cardiol 2007;75(Supl 3). [ Links ]

    10. Perloff D, Grim C, Flack J, Frohlich ED, Hill M, McDonald M. Human blood pressure determination by sphygmomanometry. Circulation 1993;88:2460-70. [ Links ]

    11. Mancia G, Bombelli M, Facchetti R, Madotto F, Quarti-Trevano F, Polo Friz H, et al. Long-term risk of sustained hypertension in white-coat or masked hypertension. Hypertension 2009;54:226-32. [ Links ]

    12. Gustavsen PH, Høegholm A, Bang LE. Kristensen KS. White coat hypertension is a cardiovascular risk factor: a 10-year follow-up study. J Hum Hypertens 2003;17:811-7. [ Links ]

    13. Fagard RH, Cornelissen VA. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens 2007;25:2193-8. [ Links ]

    14. Pierdomenico SD, Lapenna D, Di Mascio R, Cuccurullo F. Short- and long-term risk of cardiovascular events in white coat hypertension. J Hum Hypertens 2008;22:408-14. [ Links ]

    15. Palatini P, Mormino P, Santonastaso M, Mos L, Dal Follo M, Zanata G, et al. Target-organ damage in stage I hypertensive subjects with white coat and sustained hypertension. Results from the HARVEST Study. Hypertension 1998;31:57-63. [ Links ]

    16. Mulè G, Nardi E, Cottone S, Cusimano P, Incalcaterra F, Palermo A, et al. Metabolic syndrome in subjects with white-coat hypertension: Impact on left ventricular structure and function. J Hum Hypertens 2007;21:854-60. [ Links ]

    17. Björklund K, Lind L, Vessby B, Andrén B, Lithell H. Different metabolic predictors of white-coat and sustained hypertension over a 20-year follow-up period: a population-based study of elderly men. Circulation 2002;106:63-8. [ Links ]

    18. Staessen JA, Fagard RH, Lijnen PJ, Thijs L, Van Hoof R, Amery A. Mean and range of the ambulatory pressure in normotensive subjects from a meta-analysis of 23 studies. Am J Cardiol 1991;67:723-7. [ Links ]

    19. Koren MJ, Savage DD, Casale PN, Laragh JH, Devereux RB. Changes in left ventricular mass predict risk in essential hypertension. Circulation 1990;82:29-32. [ Links ]

    20. De Simone G, Devereux RB, Koren MJ, Mensah GA, Casale PN, Laragh JH. Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension. Circulation 1996;93:259-65. [ Links ]

    21. Verdecchia P, Carini G, Circo A, Dovellini E, Giovannini E, Lombardo M, et al. The MAVI Study Group. Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study. J Am Coll Cardiol 2001;38:1829-35. [ Links ]

    22. Sega R, Trocino G, Lanzarotti A, Carugo S, Cesana G, Schiavina R, et al. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation 2001;104:1385-92. [ Links ]